... in learning, reward, and motivation, as well as inhibitory control. Currently applied therapeutic approaches aim at modification of behavior that ultimately leads to decrease of consumption or abstinence in individuals with substance use disorders. However, traditional treatment methods might benefit from...

... to in the content or advertisements. Orexin A mRNA Promoter methylation Tetrahydrocannabinol Cannabis dependence Nicotine dependence Treatment Naturalistic study Psychoactive preparations of Cannabis sativa have been used for medical or religious purposes for over 4,000 years [ 1 ]. Cannabis...

... (psychometrical level). The objective electrophysiological data (neuropsychophysiological level) support these findings. Of particular interest is that following cyclandelate treatment the absolute theta power remained almost unchanged and an increase of P300 amplitude was observed. At the same time placebo led...

... consistent with DSD showed no change in MHPG after 6 weeks of treatment. This was true for both treatment responders and nonresponders. The lack of change in low levels of MHPG suggests that reduced norepinephrine turnover is a biological trait of DSD patients. Implications of this finding are discussed. ©...

... and treatment of BPD. These findings may have direct clinical implications as they offer a new avenue for attempts to develop more specific drugs for the disorder. Protein kinase C Affective disorders Depression Animal model Treatment Growth-associated protein of 43 kDa Original Paper...

...Nikolaus Michael; Hildegard Sourgens; Volker Arolt; Andreas Erfurth Tardive dyskinesia caused by antipsychotic treatment is a severe problem not only in the management of schizophrenia, but also of affective disorders. Vitamin E monotherapy has been used in schizophrenic patients with tardive...

... symptoms despite treatment and regular visits. 27% suffered from a rapid-cycling course during the follow-up period. Recurrences were significantly associated with bipolar I disorder, an additional comorbid Axis I disorder, rapid cycling in history, a higher number of mood stabilizers and the long-term use...

... of those that potentiate serotonergic mechanisms. Recent double-blind placebo-controlled studies report the efficacy of selective serotonin reuptake inhibitors. Several cognitive-behavioral and psychosocial treatments have also been reported to be efficacious and could be considered when treating PTSD...

...Willem A. Nolen; Dieneke Bloemkolk A review of the methodology and results of 9 controlled studies on the acute treatment of bipolar depression and the risk of switches into (hypo)mania is presented. There are indications but no proof for efficacy of mood stabilizers such as lithium, carbamazepine...

... to in the content or advertisements. Depression Sleep Direct and indirect costs Treatment Antidepressants Tricyclic antidepressants Selective serotonin reuptake inhibitors Nefazodone Biological Psychiatry Main Editor: J. Mendlewicz (Brussels) Original Paper Neuropsychobiology 2000;42:107 119...